Ponya Therapeutics leverages our proprietary processing capabilities to develop human tissue-derived allografts that support a wide range of clinical applications. Our approach is centered on preserving the natural structure and integrity of native tissue components while enabling consistent, scalable manufacturing.

Through processing techniques designed for minimal manipulation, we maintain key characteristics of native tissue while ensuring compliance with applicable regulatory frameworks. This balance of innovation and discipline allows us to deliver products that are both scientifically grounded and operationally reliable.

Our integrated platform spans the full lifecycle, from donor tissue coordination and processing to sterilization, packaging, and labeling, creating a streamlined pathway from tissue to finished product. Combined with controlled manufacturing environments and validated processes, our technology supports both development-stage programs and commercial-scale production.